| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.24 | 3e-07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.22 | 8e-07 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-06 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.23 | 3e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.3 | 2e-05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-05 |